466 results
The role and evolution of imaging in tricuspid interventions
18 May 2022 – From EuroPCR 2022
In this interview, João Cavalcante and Alessandro Sticchi discuss the evolving role and evolution of advanced imaging in tricuspid interventions.
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
Treating tricuspid regurgitation percutaneously: tools and impacts
19 May 2022 – From EuroPCR 2022
Discover the tools and impacts of treating tricuspid regurgitation percutaneously by watching the cases of valve replacement, valve-in-ring implantation, transcatheter edge-to-edge repair and many more.
What did 2022 tell us so far in interventions? Essential publications from the EuroIntervention Journal and the European Heart Journal
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session lists the best EIJ and EHJ publications in terms of coronary interventions, intravascular imaging and physiology, interventions for mitral and tricuspid valve disease, and interventions for aortic valve disease.
TriClip therapy: here now, here to stay
19 May 2022 – From EuroPCR 2022
Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.
